CarreraF., SilvaJ.G., PiresC., OliveiraC.. Prevalence of non-A, non-B hepatitis and antiHCV antibodies in a Portoguese dialysis population.Nephrol Dial Transplant1992; 7: 913–6.
2.
FabriziF., RaffaeleL., BacchiniG.. Antibodies to hepatitis C virus (HCV) in chronic haemodialysis patients: a study with second generation assays.Nephrol Dial Transplant1993; 8: 744–7.
3.
GetzugT., LindsayK., BrezinaM., GitnickG.. Hepatitis C virus antibody in hemodialysis patients: prevalence and risk factors.Lancet1990; 335: 589 (letter).
4.
DenticoP., BuongiornoR., VolpeA.. Prevalence and incidence of hepatitis C virus in hemodialysis patients: study of risk factors.Clin Nephrol1992; 38: 49–52.
5.
MondelliM.U., CristinaG., PiazzaV., CerinoA., VillaG., SalvadeoA.. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay.Nephron1992; 61: 350–1.
6.
ZeldisJ.B., DepnerT.A., KutamotoI.K., GishR.G., HollandP.V.. The prevalence of hepatitis C virus among hemodialysis patients.Ann Intern Med1990; 112: 958–60.
7.
HardyN.M., SandroniS., DanielsonS., WilsonW.J.. Antibody to hepatitis C virus increases with time on hemodialysis.Clin Nephrol1992; 38: 44–8.
8.
OguchiH., MiyasakaM., TokunagaS.. Hepatitis virus (HBV and HCV) in eleven Japanese hemodialysis units.Clin Nephrol1992; 38: 36–43.
9.
FabriziF., MarcelliD., BacchiniG., GuarnoriI., ErbaG., LocatelliF.. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.Nephrol Dial Transplant1994; 9: 780–4.
10.
JeffersU., PerezO.G., De MedinaM.D.. Hepatitis C infection in two urban hemodialysis units.Kidney Int1990; 38: 320–2.
11.
ValderrabanoF., JonesE.H.P., MallickN.P.. Report on management of renal failure in Europe. XXIV, 1993.Nephrol Dial Transplant1995; 10 (suppl. 5): 1–25.
12.
GeerlingsW., TufvesonG., EhrichJ.H.H.. Report of the management of renal failure in Europe, XXIII.Nephrol Dial Transplant1994; 9: 6–25.
13.
JadoulM., CornuC., van Ypersele de StrihouC., and the Universitaires Cliniques St-Luc (UCL) Collaborative Group. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian multicenter study.Kidney Int1998; 53: 1022–5.
14.
LombardiM., CerraiT., GeattiS.. Results of a national epidemiological investigation on HCV infection among dialysis patients.J Nephrol1999; 12: 322–7.
15.
KatsoulidouA., ParaskevisD., KalapothakiV., for the Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit.Nephrol Dial Transplant1999; 14: 1188–94.
16.
AllanderT., MedinC., JacobsonS.H., GrillnerL., PerssonM.A.A.. Hepatitis C transmission in a haemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment.J Med Virol1994; 43: 415–9.
17.
OlmerM., BouchouarebD., ZandottiC., De MiccoP., De LamballerieX.. Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial infection.Clin Nephrol1996; 47: 263–70.
18.
StuyverL., ClaeysH., WyseurA.. Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission.Kidney Int1996; 49: 889–95.
19.
SampietroM., BadalamentiS., SalvadoriS.. High prevalence of a rare hepatitis C virus in patients treated in the same dialysis unit: evidence for nosocomial transmission of HCV.Kidney Int1995; 47: 911–7.
20.
MizunoM., HiguchiI., KanmatsuseK., EsumiM.. Genetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C virus in haemodialysis units.J Clin Microbiol1998; 36: 2926–31.
21.
IzopetJ., PasquierC., SandresK., PuelJ., RostaingL.. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit.J Med Virol1999; 58: 139–44.
22.
IrishD.N., BlakeC., ChristophersJ.. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening.J Med Virol1999; 59: 135–40.
23.
Le PogamS., Le ChapoisD., ChristenR., DuboisF., BarinF., GoudeauA.. Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission.J Clin Microbiol1998; 36: 2926–31.
24.
SchneebergerP.M., ToonenN., KeurI., van HamersveltH.K.. Infection control of hepatitis C in Dutch dialysis centres.Nephrol Dial Transplant1998; 13: 3037–40.
25.
JimenezD.A., Sanchez-PayaJ., GonzalesC., RiveraF., AntolinA.. Audit on the degree of application of universal precautions in a haemodialysis unit.Nephrol Dial Transplant1999; 14: 1001–3.
26.
CarameloC., De SequeraP., LopezM.D., OrtizA.. Hand-borne mechanisms of dissemination of hepatitis C in dialysis units: basis for new addenda to the present preventive strategies.Clin Nephrol1999; 51: 59–60 (letter).
27.
ValderrabanoF., BertouxF.C., Mehls0. Report on the management of renal failure in Europe. XXV, 1994.Nephrol Dial Transplant1995; 11 (suppl 1): 16–7.
28.
TodorovV., BonevaR., IlievaP., DoichinovaT., DonchevM.. High prevalence of hepatitis C virus infection in one dialysis center in Bulgaria.Nephron1998; 79: 222–3 (letter).
29.
CovicA., lancuL., ApetreiC., ScripcaruD., VolovatC., MititiucI., CovicM.. Hepatitis virus infection in haemodialysis patients from Moldavia.Nephrol Dial Transplant1999; 14: 40–5.
30.
Rais-JalaliG., KhajehdehiP.. Anti-HCV seropositivity among haemodialysis patients of Iranian origin.Nephrol Dial Transplant1999; 14: 2055–6 (letter).
31.
SaynerA.A., ZeytinogluA., OzkahyaM.. HCV infection in haemodialysis and CAPD patients.Nephrol Dial Transplant1998; 14: 256–7 (letter).
32.
ZamirD., StorchS., ZonderH.B., ZamirC., WeinerP.. Hepatitis C virus seroconversion and genotype prevalence in patients and staff on chronic hemodialysis.J Clin Gastroenterol1999; 28: 23–8.
33.
TokarsJ.I., MillerE.R., AlterM.J., ArduinoM.J.. National surveillance of dialysis associated diseases in the United States, 1995.ASAIO J1998; 44: 98–107.
34.
MarcelliD., StanhardD., ConteF., HeldP.J., LocatelliF., PortF.K.. ESRD patient mortality with adjustement for comorbid conditions in Lombardy (Italy) versus the Unites States.Kidney Int1996; 50: 1013–8.
35.
LocatelliF., MarcelliD., ConteF.. 1983 to 1992: report on regular dialysis and transplantation in Lombardy.Am J Kidney Dis1995; 25: 196–205.
36.
MaisonneuveP., AgodoaL., GellertR.. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.Lancet1999; 354: 93–9.
37.
RampinoT., ArbustiniE., GregoriniM.. Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor.Kidney Int1999; 56: 2286–91.
38.
PereiraB.J.G., NatovS.N., BouthotB.A., and The New England Organ Bank Hepatitis C Study Group. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease.Kidney Int1998; 53: 1374–81.
39.
EstebanJ.I., GomezJ., MartellM.. Transmission of hepatitis C virus by a cardiac surgeon.N EngI J Med1996; 334: 555–60.
40.
McHutchisonJ.G., GordonSg, SchiffE.R., for the Hepatitis Interventional Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C.N Engl J Med1998; 339: 1485–92.
41.
AlterH.J., Sanchez-PescadorR., UrdeaM.S.. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.J Vir Hepatitis1995; 2: 121–32.
42.
YoungK.K., ArcherJ.J., YokosukaO., OmataM., ResnickR.M.. Detection of hepatitis C virus RNA by a combined reverse transcription POR assay: comparison with nested amplification and antibody testing.J Clin Microbiol1995; 33: 654–7.
43.
FabriziF., MartinP., DixitV.. Quantitative assessment of HCV viral load in patients on chronic haemodialysis: a cross-sectional survey.Nephron1998; 80: 428–33.
44.
UmlauftF., GruenewaldK., WeissG.. Patterns of hepatitis C viremia in patients receiving hemodialysis.Am J Gastroenterol1997; 92: 73–8.
45.
MartinP., CarterD., FabriziF.. Histopathological features of hepatitis C in renal transplant candidates.Transplantation2000 (in press).
46.
DuBoisD.B., GretchD., dela RosaC.. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related differences.Am J Kidney Dis1994; 24: 795–801.
47.
De MedinaM., LaRueS., HillM.. Quantitative detection of hepatitis C virus RNA in patients undergoing hemodialysis.ASAIO J1997; 43: 19–22.
48.
NaitoM., HayashiN., HagiwaraH.. Serial quantitative analysis of serum hepatitis C virus RNA levels in patients with acute and chronic hepatitis C.J Hepatol1994; 20: 755–9.
49.
GretchD., HanJ., WilsonJ.. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high titer viremia correlates with advanced stage of disease.J Infect Dis1994; 169: 1219–25.
50.
EysterM.E., FriedM.W., Di BisceglieA.M., GoedertJ.J.. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study.Blood1994; 84: 1020–3.
51.
ChazouilleresO., KimM., CombsC.. Quantitation of hepatitis C virus RNA in liver transplant recipients.Gastroenterology1994; 106: 994–9.
52.
GhanyM.G., ChanT.M., Sanchez-PescadorR., UrdeaM., LokA.S.F.. Correlation between serum HCV RNA and aminotransfersae levels in patients with chronic HCV infection.Dig Dis Sci1996; 41: 2213–8.
53.
LauJ.Y.N., DavisG.L., KniffenJ.. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.Lancet1993; 341: 1501–4.
54.
FabriziF., MartinP., DixitV.. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus.Am J Kidney Dis2000; 35: 122–9.
55.
OkudaK., HayashiH., YokozekiK., IrieY.. Destruction of hepatitis C virus particles by hemodialysis.Lancet1996; 347: 909–10 (letter).
56.
AdoratiM., PipanC., BottaG.. Membrane compatibility and clearance of hepatitis C virus in chronic dialysis patients.Nephron1999; 82: 358 (letter).
57.
HayashiH., OkudaK., YokosukaO.. Adsorption of hepatitis C virus particles onto the dialyzer membrane.Artif Organs1997; 21: 1056–9.
58.
MizunoM., HiguchiT., KunoT.. Elimination of circulating hepatitis C virus from hemodialysis patients in a membrane dependent manner.Nephrol Dial Transplant1996; 11: 177A (abstract).
59.
ManziniP., AmoreA., BrunettoM.R.. Is hepatitis C virus RNA detectable in dialysis ultrafiltrate?Nephron1996; 72: 102–3 (letter).
60.
LindsayK.L., EI-ShahawyM., MilsteinS.. HCV RNA levels are lowered during hemodialysis in patients with chronic hepatitis.Hepatology1994; 20: 239A (abstract).
61.
BadalamentiS., SampietroM., LunghiG.. Riduzione della viremia HCV in corso di emodialisi.Giorn It Nefrol1997; 14(S9): 39 (abstract).
62.
PereiraB.J.G.. Hepatitis C infection in dialysis.Semin Dial1998; 11: 113–8.
63.
YuasaT., IshikawaG., ManabeS., SekiguchiS., TakeuchiK., MiyamuraT.. The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre.J Gen Virol1991; 72: 2021–4.
64.
LinH.H., HuangC.C., SheenI.S., LinD.Y., LiawY.F.. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit.Int J Artif Organs1991; 11: 192–4.
65.
GrazianiG., BadalamentiS., SampietroM.. Produzione endogena di α-interferone (α-IFN) durante emodialisi (ED) in pazienti HCV positivi.Giorn It Nefrol1998; 15: 191 (abstract).
66.
RostaingL., ChatelutE., PayenJ.L.. Pharmacokinetics of alpha FN-2b in chronic hepatitis C virus in patients undergoing chronic hemodialysis or with normal renal function: clinical implications.J Am Soc Nephrol1998; 9: 2344–8.
67.
UchiharaM., IzumiN., SakaiY.. Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon.Nephron1998; 80: 51–6.
68.
ClarkW.R., MaciasW.L., MolitorisB.A., WangN.H.L.. Plasma protein adsorption to highly permeable hemodialysis membranes.Kidney Int1995; 48: 481–8.
69.
ClarkW.R., HamburgerR.J., LysaghtM.J.. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.Kidney Int1999; 56: 2005–15.
70.
ChanT.M., WuP.C., LauJ.Y.N., LokA.S.F., LaiC.L., ChengI.K.P.. Interferon treatment for hepatitis C virus infection in patients on hemodialysis.Nephrol Dial Transplant1997; 2: 1414–9.
71.
De JoungG.M.T., De BruinW., VerresenL., MoshageH., DesmyterJ., YapS.H.. High flux membranes are not permeable to hepatitis B virus-DNA.Nephron1992; 60: 368 (letter).
72.
KroesA.C.M., van BommelE.F.H., NiestersH.G.M., WeimarW.. Hepatitis B viral DNA detectable in dialysate.Nephron1994; 67: 369 (letter).
73.
MartinP., FriedmanL.. Chronic viral hepatitis and the management of chronic renal failure.Kidney Int1995; 47: 1231–41.
